News & Updates

Gilead’s remdesivir prevents Covid-19 progression in preclinical study


Excerpt from the article: A preclinical study in the US found that Gilead Sciences’ antiviral drug candidate remdesivir prevented disease progression in rhesus macaques monkeys with Covid-19. “The animals were infected with the novel coronavirus, SARS-CoV-2. Data announced by the National Institutes of Health (NIH) revealed a significant decrease in clinical disease and reduced lung…

Read More

Nuritas Leverages AI Platform to Identify Therapeutic Peptides for the Treatment of COVID-19


Excerpt from the article: “CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nuritas, a biotechnology company that is revolutionizing the discovery and use of therapeutic peptides through artificial intelligence (AI) and genomics, today announced that it has received a grant from Partnership for Advanced Computing in Europe (PRACE) to identify therapeutic peptides for the treatment of patients with COVID-19. Under the…

Read More

How Johnson & Johnson is Mobilizing Their Resources to Help Find Solutions for Covid-1


J&J is launching a new video series documenting their process towards developing a vaccine for COVID-19. Excerpt from their announcement: “This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine. Each week our host Lisa Ling will talk…

Read More

INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data With DNA Vaccine INO-4700 for MERS Coronavirus at the American Society of Gene & Cell Therapy (ASGCT) Conference


Excerpt from the press release: “PLYMOUTH MEETING, Pa. and SEOUL, South Korea, April 28, 2020 /PRNewswire/ — INOVIO (NASDAQ:INO) and GeneOne Life Science (KSE:011000) today announced interim data through week 16 from a Phase 1/2a trial of DNA vaccine INO-4700 (also called GLS-5300) for MERS coronavirus (MERS-CoV). Vaccine recipients demonstrated strong antibody and T cell immune…

Read More

How BlueDot spots warning signs of pandemics


Excerpt from the article: “When it comes to viral outbreaks, every day is valuable: stopping a pandemic means getting the right information to the right people at the right time. BlueDot identified the emerging risk of COVID-19 in Hubei province eight days before the World Health Organization.” Click the button below to read the entire…

Read More

Vaxart Plans to Push COVID-19 Vaccine Candidate into the Clinic


Excerpt From the Article: Bay Area-based Vaxart, Inc. has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose. Now, the company plans to push one or more into the clinic. Sean Tucker, Vaxart’s chief scientific officer, said the…

Read More

Low-dose CT works well for COVID-19 assessment


Excerpt from the article: April 23, 2020 — Chest CT at a radiation dose under 1 mSv can accurately and rapidly assess COVID-19 infection in emergency room patients — particularly those who have had symptoms longer than 48 hours, according to a study published April 21 in Radiology: Cardiothoracic Imaging. The results are good news…

Read More

This sensor could detect COVID-19 in the air


Excerpt From the Article: Researchers at the Swiss Federal Laboratory have developed a sensor that could potentially quickly and reliably detect SARS-CoV-2, the COVID-19 virus. Prior to the coronavirus spreading around the world, Jing Wang and his colleagues were researching sensors that could detect bacteria and viruses in the air. The concept of the sensor…

Read More

Anyone with a computer can help this Covid-19 project


Excerpt from the article: The Washington University School of Medicine’s Folding@home project will utilise supercomputers at the Science and Technology Facilities Council (STFC) Hartree Centre to better understand protein behaviour in diseases. The project is calling on anyone with a personal computer to help out, as they can lend any unused background capacity to help…

Read More

Building a bridge to a COVID-19 vaccine


Excerpt from the article: Regeneron has shared high hopes for its two candidates in the fight against COVID-19 on the first day of the four-day eyeforpharma Philadelphia virtual event. George Yancopolous, President and Chief Scientific Officer at Regeneron, revealed that the company expected to have a good idea of the prospects for Kevzara, one…

Read More

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?